Early Access — free while we kick the tires
EdgarHawk

MRSH MARSH & MCLENNAN COMPANIES, INC. Insider Trading

Latest: President and CEO Sold $2.7M of Shares · Jun 2026

Multiple insiders have been active at MARSH & MCLENNAN COMPANIES, INC. (MRSH): 9 distinct insiders account for 1 buy filing and 18 sell filings as of Jun 2026. Its highest-significance filing in the last 90 days: President and CEO John Q Doyle sold $2.7M, transaction dated Jun 2026.

19 filings analyzed · Latest 2026-06-03

Get alerts for MRSH

Free Form 4 email alerts, scored for significance — see how.

Buys
1
Sells
18
Insiders
9
Direction
Net selling

MARSH & MCLENNAN COMPANIES, INC. leadership

CEO
John Q. Doyle — CHIEF EXECUTIVE OFFICER
CFO
Mark C. McGivney — CHIEF FINANCIAL OFFICER
General Counsel
Connor Kuratek — Deputy General Counsel & Corporate Secretary
Chair
H. Edward Hanway — Independent Chair

Historically, stocks have lagged the S&P 500 by a median ~3% over the 90 days after a medium insider sell (n ≈ 4,738, 2024-2026). Past results don't predict the future. How we measure this ↗

June 2026
2026-06-03 10b5-1 Plan
medium
President and CEO
16,656 shares
$2,693,442
@ $161.71
Significance 5

CEO John Q Doyle sold 16,656 shares of MRSH at $161.71 on 2026-06-02 via pre-arranged 10b5-1 plan; holds 116,811 non-derivative shares post-transaction.

President and CEO John Q Doyle executed a scheduled sale of 16,656 shares at $161.71 under a pre-arranged 10b5-1 trading plan on 2026-06-02, reducing his non-derivative holdings to 116,811 shares from 133,467 shares (-12.5%). The transaction is part of a predetermined plan rather than a discretionary decision, removing timing-based interpretation. The stock has since declined 18.6% from its 52-week high of $193.32 and is currently trading at $157.32, below the transaction price. While this marks a scheduled vest-and-sell action, Doyle retains 33,312 shares through stock options, maintaining meaningful economic exposure to the company. The company remains fundamentally healthy with $7.6B in quarterly revenue, $1.1B in net income, and a P/E of 19.30.

March 2026
2026-03-05 10b5-1 Plan
medium
President and CEO
16,655 shares
$3,052,862
@ $183.30
Significance 5

CEO John Q Doyle sold 16,655 MRSH shares at $183.30 on 2026-03-04 ($3.1M); holds 133,466 shares post-sale.

CEO Doyle sold 16,655 shares at $183.30, representing an 11.1% reduction in his holdings. His cross-ticker track record shows 4 prior open-market sales with an average 90-day return of -5.7% and a 75.00% well-timed rate, indicating historically strong timing on sell decisions. The stock is currently trading at $185.00, 2.5% below the 52-week high, and has declined 1.8% over the past 30 days. MRSH fundamentals show strong quarterly revenue of $6,351,000,000.00 with net income of $747,000,000.00 and annual revenue growth of 10.3%. This sale occurs in a stable operational context where the CEO maintains substantial holdings of 133,466 shares post-transaction.

December 2025
2025-12-02 10b5-1 Plan
medium
President and CEO
21,079 shares
$3,841,015
@ $182.22
Significance 4

MMC CEO Doyle sells 21,079 shares ($3.8M) via 10b5-1 plan; holds 87,681 shares post-sale

CEO John Q Doyle executed a 21,079-share sale of MMC at $182.22 on 2025-12-01 for $3,841,015.38, reducing his holdings from 108,760 shares to 87,681 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it is scheduled and non-discretionary rather than a signal of changed executive sentiment. The sale represents a -19.4% reduction in his pre-transaction holdings, a material decrease in absolute position size, though the CEO retains substantial equity ownership. As a scheduled disposition under Rule 10b5-1, the transaction does not carry timing-based inference about near-term company outlook.

September 2025
2025-09-03 10b5-1 Plan
low
President and CEO
21,079 shares
$4,334,896
@ $205.65
Significance 3

Marsh & McLennan CEO John Q Doyle sells 21,079 shares ($4.3M) under pre-arranged 10b5-1 plan

John Q Doyle, President and CEO of Marsh & McLennan Companies, sold 21,079 shares at $205.65 on 2025-09-02 for a total value of $4,334,896.35, reducing his holdings from 108,760 shares to 87,681 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled in advance rather than a discretionary trade. The sale represents a 19.4% reduction in his pre-transaction holdings. Since this sale is governed by a 10b5-1 plan, it reflects a predetermined trading strategy rather than a response to current market conditions or company developments.

July 2025
2025-07-31
medium
1,000 shares
$201,612
@ $201.61
Significance 6

Director Anthony Anderson purchases 1,000 shares in 2 tranches for $201,612.50, doubling holdings to 2,000 shares

Director Anderson Anthony executed 2 separate purchases totaling 1,000 shares for $201,612.50 on 2025-07-29 and 2025-07-30, at blended average price of $201.61. This doubled his pre-transaction holdings from 1,000 shares to 2,000 shares (+100.0%). At current price of $199.20, the stock is -18.4% from its 52-week high of $244.27 and has declined -8.6% over the past 30 days. The timing of this purchase during a recent downtrend, combined with the director's full doubling of his shareholding in consecutive days, contrasts with the stock's recent price weakness and suggests conviction in the company's fundamental value. Marsh & McLennan maintains solid fundamentals with $7.0B in latest quarterly revenue, $1.2B net income, and annual revenue growth of +7.6%, alongside a P/E of 23.74.

June 2025
2025-06-03 10b5-1 Plan
medium
President and CEO
21,080 shares
$4,891,614
@ $232.05
Significance 6

CEO Doyle sold 21,080 MMC shares at $232.05 ($4.9M); 19.4% reduction in holdings to 87,681 shares.

Doyle John Q, President and CEO of Marsh & McLennan, sold 21,080 shares for $4,891,614.00, reducing his holdings by 19.4% from 108,761 to 87,681 shares. The sale occurred at $232.05, below the current price of $234.86 and within recent trading range. Notably, his prior sell at MMC on 2025-03-03 posted a 90-day return of -1.4%, meaning the stock declined after that earlier sale. His cross-ticker track record shows 1 prior sell with a 90d well-timed rate of 100.00%, indicating a pattern of selling ahead of downturns. The company's fundamentals show solid performance with $7.1B in quarterly revenue, $1.4B net income, and 7.6% annual revenue growth, though the P/E of 28.64 reflects current market valuation.

April 2025
2025-04-07 10b5-1 Plan
low
SVP, Chief Information Officer
2,237 shares
$550,302
@ $246.00
Significance 4

SVP CIO Beswick Paul sold 2,237 shares of MMC at $246.00, reducing holdings 14.2%; stock now -8.4% from 52-week high.

Beswick Paul, SVP and Chief Information Officer, sold 2,237 shares at $246.00 on 2025-04-03, generating $550,302.00 in proceeds and reducing his holdings from 15,759 to 13,522 shares. The sale occurred near the 52-week high range ($244.27), with the stock currently trading at $223.74, representing a -8.4% decline from the 52-week high. Examining his prior sales at MMC, only 1 of 5 prior transactions showed negative 90-day returns (well-timed); his cross-ticker track record shows 20.00% of prior sells were well-timed with an average 90-day return of +2.0%, indicating his prior sales have generally not preceded significant declines. The company's fundamentals remain solid with $5.7B quarterly revenue, +7.6% annual growth, and a P/E of 25.37, providing no obvious operational distress signal.

2025-04-01 10b5-1 Plan
low
President & CEO, Guy Carpenter
9,569 shares
$2,344,405
@ $245.00
Significance 4

CEO Dean Michael Klisura sold 9,569 shares of MMC at $245.00 for $2,344,405.00; stock near 52-week high

Dean Michael Klisura, President & CEO of Guy Carpenter, sold 9,569 shares (31.4% of his pre-transaction holdings) at $245.00 on 2025-03-31, reducing his stake to 20,935 shares. The sale occurred near the company's 52-week high ($244.03), with the stock currently at $244.00 and up 14.9% over 90 days and 2.6% over 30 days. His cross-ticker track record shows a 90-day well-timed rate of 33.33% across all open-market sells, but at Marsh & McLennan specifically, only 1 of 3 prior measurable sells exhibited positive 90-day returns—a weak track record at this ticker. The company shows solid fundamentals (P/E 27.66, $5.7B in latest quarterly revenue, 7.6% annual growth), suggesting the sale reflects portfolio management rather than company-specific concern.

March 2025
2025-03-11 10b5-1 Plan
low
Chief Financial Officer
10,510 shares
$2,469,535
@ $234.97
Significance 3

CFO Mark McGivney sold 10,510 shares of MMC at $234.97 ($2.5M) via pre-arranged 10b5-1 plan

Mark McGivney, Chief Financial Officer of Marsh & McLennan Companies, sold 10,510 shares for $2,469,534.70 under a pre-arranged 10b5-1 trading plan, reducing his holdings from 44,188 to 33,678 shares. As a scheduled transaction, this sale reflects programmatic portfolio execution rather than discretionary timing decisions. The CFO retains substantial ownership with 33,678 shares post-transaction, indicating continued meaningful equity stake in the company.

2025-03-11 10b5-1 Plan
medium
President & CEO, Guy Carpenter
7,121 shares
$1,673,221
@ $234.97
Significance 5

CEO Klisura Dean Michael sells 7,121 MMC shares at $234.97; holdings drop 25.4% to 20,935 shares.

Klisura Dean Michael, President & CEO of Guy Carpenter (a division of Marsh & McLennan), sold 7,121 shares at $234.97 on 2025-03-10 for $1,673,221.37, reducing his holdings by 25.4%. At his same-ticker history at MMC, his prior sells have delivered mixed timing: the 2024-03-08 and 2024-03-04 sales generated positive 30-day and 90-day returns, while the 2023-07-26 sale produced a -1.7% 90-day return, yielding a 33.33% well-timed rate across his three prior MMC sales. The current stock price of $233.11 lies 2.7% below the 52-week high and reflects recent momentum (30-day +2.5%, 90-day +8.8%), while MMC maintains solid fundamentals with $5.7B revenue, $747.0M net income, and 7.6% annual growth at a P/E of 26.43. The sale occurs near a price peak and follows a pattern of generally positive post-sale returns at this ticker, though the volume and proximity to the 52-week high merit observation relative to prior disposal patterns.

More Insurance Agents, Brokers and Service companies